98 related articles for article (PubMed ID: 338643)
21. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.
Andersen JR; Schroeder E; Lebech PE
Acta Endocrinol (Copenh); 1980 Dec; 95(4):433-7. PubMed ID: 6779473
[TBL] [Abstract][Full Text] [Related]
22. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
23. The effect of estrogen priming of hypogonadal women on the release of gonadotropins and prolactin in response to 2-hydroxyestradiol.
Adashi EY; Fishman J; Yen SS
Life Sci; 1982 Nov; 31(18):1903-9. PubMed ID: 6817001
[TBL] [Abstract][Full Text] [Related]
24. [Clinical pharmacology of hormonal contraceptives].
Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
[No Abstract] [Full Text] [Related]
25. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
26. Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 -oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones.
Leyendecker G; Wardlaw S; Nocke W
Acta Endocrinol (Copenh); 1972 Sep; 71(1):160-78. PubMed ID: 4678011
[TBL] [Abstract][Full Text] [Related]
27. Feedback modulation of hypothalamic-pituitary unit by estrogen in the secretion of gonadotropins and prolactin in humans.
Yen SS; Siler TM; VandenBerg G; Ehara Y
Adv Biosci; 1975; 15():163-80. PubMed ID: 809301
[No Abstract] [Full Text] [Related]
28. Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
Nishi T; Nakano R; Yagi S
Horm Res; 1989; 32(5-6):193-7. PubMed ID: 2517493
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Spona J; Huber J; Schmidt JB
Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
[TBL] [Abstract][Full Text] [Related]
30. [Serum prolactin and gonadotropins during the normal menstrual cycle and during oral contraceptives].
Vekemans M; L'Hermite M; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):354-6. PubMed ID: 4143445
[No Abstract] [Full Text] [Related]
31. Effects of gonadotropin-releasing hormone and estrogen on serum levels of human chorionic gonadotropin-like substance in postmenopausal women.
Nakano R; Yamoto M; Nishi T; Fujinaga H
Fertil Steril; 1990 Jul; 54(1):161-3. PubMed ID: 2113487
[No Abstract] [Full Text] [Related]
32. [Daily fluctuation of the follicle-stimulating (FSH) and luteinizing (LH) hormone in the human plasma].
Leyendecker G; Saxena BB
Klin Wochenschr; 1970 Feb; 48(4):236-8. PubMed ID: 5523315
[No Abstract] [Full Text] [Related]
33. The effect of ethinyl estradiol administration during the follicular phase of the menstrual cycle on LH, FSH, progesterone and estradiol levels in the subsequent luteal phase.
Dhont M; Vandekerckhove D; Vermeulen A
J Clin Endocrinol Metab; 1974 Sep; 39(3):465-70. PubMed ID: 4416191
[No Abstract] [Full Text] [Related]
34. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
[TBL] [Abstract][Full Text] [Related]
35. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
De Leo V; Petraglia F; Bruno MG; Lanzetta D; Inaudi P; D'Antona N
Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of RU 16117, a potent estrogen antagonist, on the estrous cycle in the rat.
Ferland L; Labrie F; Kelly PA; Raynaud JP
Biol Reprod; 1978 Feb; 18(1):99-104. PubMed ID: 342001
[No Abstract] [Full Text] [Related]
37. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
38. Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin.
Chang RJ; Davidson BJ; Carlson HE; Judd HL
Am J Obstet Gynecol; 1982 Oct; 144(4):402-7. PubMed ID: 7124858
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
40. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
